Pages
Products
Panoply™ Human CD52 Over-expressing Stable Cell Line

Panoply™ Human CD52 Over-expressing Stable Cell Line

Cat.No. :  CSC-SC002757 Host Cell:  HEK293 (CHO and other cell types are also available)

Inquire for Price

Cell Line Information

Cell Culture Information

Safety and Packaging

Cat. No. CSC-SC002757
Description Using Creative Biogene's proprietary lentiviral vectors, we subclone the target gene into lentivector, generate the lentivirus particles, sequentially infect the cell line HEK293 (other cell types are also available according to your requirements), and select the clones constantly expressing target gene at high level.
Gene CD52
Gene Species Homo sapiens (Human)
Host Cell HEK293 (CHO and other cell types are also available)
Stability Validated for at least 10 passages
Application

1. Gene expression studies

2. Signaling pathway research

3. Drug screening and toxicology

4. Disease research

Quality Control Negative for bacteria, yeast, fungi and mycoplasma.
Size Form 2 × 10^6 cells / vial
Shipping Dry Ice
Storage Liquid nitrogen
Revival Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media.
Mycoplasma Negative
Format One frozen vial containing millions of cells
Storage Liquid nitrogen
Safety Considerations

The following safety precautions should be observed.

1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum.

2. No eating, drinking or smoking while handling the stable line.

3. Wash hands after handling the stable line and before leaving the lab.

4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells.

5. All waste should be considered hazardous.

6. Dispose of all liquid waste after each experiment and treat with bleach.

Ship Dry ice
Quick Inquiry

Case Study

Publications

Q & A

Customer Reviews

Systemic sclerosis (SSc) is characterized by dysregulated type I interferon (IFN) signaling. CD52 is well known for its immunosuppressive function in T cells. Here, researchers investigated the role of CD52 in monocyte adhesion and type I IFN signaling in SSc patients. Pathway enrichment analysis revealed that adhesion- and type I IFN-related genes were increased in monocytes from SSc patients. These cells had upregulated CD11b/CD18 expression, decreased CD52 expression, and enhanced adhesion to intercellular adhesion molecule 1 and endothelial cells. Changes in CD52 expression were consistent with SSc subtypes as well as immunosuppressive therapy, autoantibody profiles, and monocyte adhesion properties in SSc patients. CD52 overexpression resulted in decreased levels of CD18 and monocyte adhesion, whereas CD52 knockdown increased monocyte adhesion. In blood samples from healthy controls, the humanized anti-CD52 monoclonal antibody alemtuzumab demonstrated increased monocyte adhesion and CD11b/CD18 expression and enhanced type I interferon responses. Monocyte CD52 expression is upregulated by interleukin-4 (IL-4)/IL-13 via the STAT6 pathway, whereas it is downregulated by lipopolysaccharide and interferons α, β, and γ in a JAK1- and histone deacetylase IIa (HDAC IIa)-dependent manner. Downregulation of the antiadhesive CD52 antigen in CD14+ monocytes represents a novel mechanism in the pathogenesis of systemic sclerosis (SSc).

Compared with control cells, CD52-overexpressing monocytes showed reduced adhesion levels to culture plates coated with ICAM1-Fc, ICAM2-Fc, and VCAM1-Fc, as well as to TNFα-activated endothelial cells (Figure 1A, B). Therefore, the researchers observed that monocyte adhesion to endothelial cells increased when CD52 expression was inhibited. Next, the microcapillary shear flow system was used to analyze the specific stages of monocyte adhesion to activated endothelial cells. The researchers observed no difference in the number and rolling distance of rolling cells between the two groups (Figure 1C). However, CD52-overexpressing cells rolled for a shorter time, at a faster speed, and with significantly fewer final adherents (Figure 1D).

Figure 1. CD52 expression modulates adhesion of THP-1 cell line. (Rudnik M, et al., 2021)

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction